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The hepatitis C virus (HCV) nonstructural protein 4B (NS4B) is a relatively hydrophobic 27-kDa protein of unknown function.
A tetracycline-regulated gene expression system, a novel monoclonal antibody, and in vitro transcription–translation were
employed to investigate the subcellular localization and to characterize the membrane association of this viral protein. When
expressed individually or in the context of the entire HCV polyprotein, NS4B was localized in the endoplasmic reticulum (ER),
as shown by subcellular fractionation, immunofluorescence analyses, and double-label confocal laser scanning microscopy.
In this compartment NS4B colocalized with the other HCV nonstructural proteins. Association of NS4B with the ER membrane
occurred cotranslationally, presumably via engagement of the signal recognition particle by an internal signal sequence. In
membrane extraction and proteinase protection assays NS4B displayed properties of a cytoplasmically oriented integral
membrane protein. Taken together, our findings suggest that NS4B is a component of a membrane-associated cytoplasmic
HCV replication complex. An efficient replication system will be essential to further define the role of NS4B in the viral life
cycle. © 2001 Academic PressKey Words: hepatitis C virus; nonstructural proteins; endoplasmic reticulum; tetracycline-regulated gene expression
system; replication complex; in vitro transcription–translation.INTRODUCTION
The hepatitis C virus (HCV) is a major cause of chronic
hepatitis, liver cirrhosis, and hepatocellular carcinoma
worldwide (National Institutes of Health, 1997; European
Association for the Study of the Liver, 1999). HCV has
been classified in the genus Hepacivirus within the fam-
ily Flaviviridae, which includes the classical flaviviruses,
such as yellow fever virus and the animal pestiviruses
(Rice, 1996; van Regenmortel et al., 2000). HCV contains
a single-stranded, positive-sense RNA genome of ap-
proximately 9600 nucleotides (nt) in length that encodes
a polyprotein precursor of about 3000 amino acids (aa)
(see Bartenschlager and Lohmann, 2000, and Reed and
Rice, 2000, for recent reviews). The polyprotein precursor
is co- and posttranslationally processed by cellular and
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70viral proteases to yield the mature structural and non-
structural proteins (Fig. 1A). The structural proteins core,
E1, and E2 are released from the polyprotein precursor
by the endoplasmic reticulum (ER) signal peptidase of
the host cell. The nonstructural (NS) proteins include two
viral proteases, a RNA helicase located in the carboxy-
terminal region of NS3, the NS4A polypeptide, the NS4B
and NS5A proteins, and a RNA-dependent RNA polymer-
ase represented by NS5B. Cleavage of the polyprotein
precursor at the NS2–NS3 junction is accomplished in
cis by an autoprotease encoded by NS2 and the amin-
oterminal one-third of NS3. A distinct serine protease
located in the amino-terminal one-third of NS3 is respon-
sible for the downstream cleavages in the nonstructural
region. The NS4A polypeptide serves as a cofactor for
the NS3 serine protease and is incorporated as an inte-
gral component into the enzyme core. NS5A is a serine
phosphoprotein of unknown function.
NS4B, a relatively hydrophobic protein of 27 kDa, is the
least characterized HCV protein. The NS4B proteins of
HCV, pestiviruses, and flaviviruses are similar in size, aa
composition, and hydrophobic properties. No function,
however, has yet been ascribed to NS4B in any of these
related viruses. Interestingly, it has recently been shown
that hyperphosphorylation of the HCV NS5A protein de-
pends on the presence of the nonstructural proteins 3,
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mann et al., 1999). NS4B appears to be directly involved
in the modulation of NS5A hyperphosphorylation, since
two deletions in NS4B that do not affect polyprotein
processing and basal NS5A phosphorylation abolish
NS5A hyperphosphorylation (Koch and Bartenschlager,
1999). This observation, together with the demonstration
of a physical interaction between NS4A (and, by conse-
quence, also NS3) and a NS4B–5A cleavage substrate
(Lin et al., 1997), suggests that NS4B associates with the
ther nonstructural proteins to form a replication com-
lex. In this context, it has recently been shown in the
elated flavivirus Kunjin that NS4B is essential for viral
eplication and functions only in cis (Khromykh et al.,
000). Intriguingly, HCV NS4B has recently been reported
o transform NIH3T3 cells in cooperation with the Ha-ras
oncogene (Park et al., 2000).
As a first step toward determining the function of HCV
NS4B, we investigated its subcellular localization and
characterized its membrane association. For this pur-
pose, continuous human cell lines inducibly expressing
NS4B either individually or in the context of the entire
HCV polyprotein were established using a tetracycline-
regulated gene expression system, and monoclonal an-
tibodies (mAbs) were generated by hybridoma fusion.
Subcellular fractionation and double-label immunofluo-
rescence analyses revealed that NS4B was localized in
the ER, where it colocalized with the other HCV nonstruc-
tural proteins. In vitro transcription–translation experi-
ments performed in the presence or absence of micro-
somal membranes revealed cotranslational targeting to
the ER membrane, where NS4B displayed properties of a
cytoplasmically oriented integral membrane protein.
RESULTS
NS4B mAb and tetracycline-regulated cell lines
A NS4B-specific mAb of the IgG1 isotype, designated
4b-52, was obtained by hybridoma fusion after immuni-
zation of BALB/c mice with recombinant NS4B protein
produced in Escherichia coli. This mAb was found to
function well in ELISA and indirect immunofluorescence
applications, but not in immunoblot analyses, suggesting
that it recognizes a conformational epitope.
A tetracycline-regulated gene expression system was
used to generate cell lines inducibly expressing NS4B.
Screening of 60 antibiotic double-resistant clones resulting
from the transfection of the tetracycline-controlled transac-
tivator (tTA)-expressing founder cell line UTA-6 with the
construct pUHDNS4Bcon allowed the isolation of two
tightly regulated cell lines, designated UNS4Bcon-4 (high-
level expression) and UNS4Bcon-52 (medium-level expres-
sion). These cell lines were maintained in continuous cul-
ture for more than 12 months and over 50 passages with
stable characteristics and without loss of the tightly regu-
lated NS4B expression.An immunoblot analysis of UNS4Bcon-4 cells cultured
for 24 h in the presence or absence of tetracycline is
shown in Fig. 1B. No NS4B reactivity was observed when
the cells were cultured in the presence of tetracycline. By
contrast, a single NS4B-specific band of approximately
27 kDa was observed in cells cultured in the absence of
tetracycline. This illustrates the tight regulation of NS4B
expression in this cell line.
Interestingly, high-level expression of NS4B affected
viability and growth of UNS4Bcon-4 cells seeded at low
confluence. Colony formation efficiency assays did not
yield any colonies when these cells were seeded at low
confluence and subsequently cultured in the absence of
tetracycline. By contrast, the expected number of colo-
nies formed when these cells were cultured in the pres-
ence of 1 mg/ml tetracycline (i.e., when NS4B expression
was completely repressed) or when expression was ti-
trated to low levels in the presence of 0.01 mg/ml tetra-
cycline (data not shown). Consistent with the dose-de-
pendent cytotoxic effect, colony formation was not af-
fected in UNS4Bcon-52 cells, which produce lower
amounts of NS4B.
The subcellular localization of NS4B was investigated
by indirect immunofluorescence microscopy. An immu-
nofluorescence analysis of UNS4Bcon-4 cells stained
with the mAb 4b-52 is shown in Fig. 1C. No immunore-
activity was detected when the cells were cultured in the
presence of tetracycline (0 h). NS4B expression became
clearly detectable 6 h following tetracycline withdrawal
and increased to reach a steady-state level after 24 h. At
this time point, mAb 4b-52 revealed a reticular staining
pattern, which surrounded the nucleus, extended
through the cytoplasm, and appeared to include the
nuclear membrane. No nuclear or plasma membrane
staining was observed. An analogous staining pattern
was found in UNS4Bcon-52 cells (data not illustrated). In
UHCVcon-57 cells, which inducibly express NS4B in the
context of the entire HCV polyprotein, overall expression
levels were lower, but the cytoplasmic reticular staining
was very similar to that observed in UNS4Bcon-4 and
UNS4Bcon-52 cells (Fig. 3, right panel). Taken together,
the NS4B staining pattern observed in these cell lines
was typical of a membrane-associated protein and
highly suggestive of a localization of the protein in the
ER.
Subcellular fractionation experiments were performed
to confirm the membrane association of NS4B suggested
by the immunofluorescence data. For this purpose, cells
were lysed in a hypotonic buffer and separated into
nuclear, mitochondrial, microsomal, and cytosolic frac-
tions by differential centrifugation (Fig. 1D). When equal
amounts of protein from each fraction were analyzed by
immunoblot, NS4B was detected only in the membrane-
containing fractions, i.e., the nuclear pellet [which con-
tains the outer nuclear membrane (contiguous with the
ER) and membranes adsorbed to the nucleus], the mito-
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U-2 OS cells are often wrapped around mitochondria
(Moradpour et al., 1996)], and the microsomal pellet.
However, NS4B was not detected in the cytosolic frac-
tion, which contains soluble proteins. By contrast, green
fluorescent protein (GFP), a protein that is diffusely dis-
tributed within cells, was found in all fractions (Fig. 1D,
lower panel). Taken together, these results clearly dem-
onstrate the membrane association of NS4B.
NS4B is localized in the ER
FIG. 1. Tetracycline-regulated expression and subcellular localization
cells. Included HCV aa positions are indicated below. The genetic org
top. Diamonds denote cleavages of the HCV polyprotein precursor by t
proteases. Asterisks indicate glycosylation of the envelope proteins. (B
were cultured for 24 h in the presence (1) or absence (2) of tetracy
approximately 60 mg protein was separated by 12% SDS–PAGE and
epatitis C at a dilution of 1:500. Molecular weight standards in kDa ar
ere cultured in the presence (0 h) or for 6, 12, and 24 h in the absence
icroscopy using mAb 4b-52 as described under Materials and Met
ultured for 48 h in the absence of tetracycline and subsequently subje
er lane, 60 mg protein was separated by 15% SDS–PAGE and analyze
r the mAb JL-8 against GFP, respectively. nuc, nuclear; mit, mitochonThe staining pattern and the subcellular fractionation
data shown in Fig. 1 were highly suggestive of a local-ization of NS4B in the ER. Double-label confocal laser
scanning microscopy with antibodies to cellular marker
proteins was performed to explore the subcellular local-
ization of NS4B in more detail. As shown in Fig. 2, NS4B
colocalized perfectly with protein disulfide isomerase
(PDI), a marker specific for the ER. The NS4B staining
pattern observed in these cells was different, however,
from that revealed by antibodies directed against ERGIC-
53, a marker of the ER-to-Golgi intermediate compart-
ment, and mannosidase (Man) II, a marker of the Golgi
apparatus. The possibility of an association of a minor
V NS4B. (A) Expression cassettes present in UNS4Bcon and UHCVcon
n and polyprotein processing of HCV are schematically illustrated at
ignal peptidase and arrows indicate cleavages by the NS2-3 and NS3
y regulated expression of NS4B in UNS4Bcon cells. UNS4Bcon-4 cells
tet) and subsequently processed for Western blot analysis. Per lane,
d by immunoblot using a pool of sera from 10 patients with chronic
ted on the left. (C) Subcellular localization of NS4B. UNS4Bcon-4 cells
cycline and subsequently processed for indirect immunofluorescence
D) Subcellular fractionation. UNS4Bcon-4 and UGFP-9.22 cells were
subcellular fractionation as described under Materials and Methods.
munoblot using the polyclonal rabbit antiserum WU151 against NS4B
ic, microsomal; cyt, cytosolic fraction.of HC
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ized predominantly in the ER.
As found previously by us (Moradpour et al., 1996,
1998a,b) and others (Precious et al., 1995) using the
tetracycline-regulated gene expression system, there
was some heterogeneity in expression levels among
individual cells of a given monoclonal cell line. This
inherent feature of the expression system explains the
observation that not all cells stained with antibodies
against marker proteins stained for NS4B in the double-
immunolabeling experiments.
NS4B colocalizes with the other HCV nonstructural
proteins
FIG. 2. NS4B is localized in the ER. UNS4Bcon-4 cells were cultur
ouble-immunolabeling with antibodies against the indicated cellular m
1/93 against ERGIC-53, with the polyclonal antiserum WU151 against N
econdary antibodies. Slides were analyzed by confocal laser scanning
aken through the center of the nuclei are shown. Images recorded in r
n the right, respectively, and merged images are shown in the middlThe nonstructural proteins NS3 through NS5B repre-
sent an independent module sufficient for the autono-mous replication of subgenomic HCV RNA (Lohmann et
al., 1999). To further explore the role of NS4B we com-
pared the localization of NS4B with that of the other HCV
nonstructural proteins. In a first set of experiments (Fig.
3, left panels), UNS4Bcon-4 cells cultured in the absence
of tetracycline were transiently transfected with cyto-
megalovirus promoter-driven expression constructs cod-
ing for the HCV nonstructural proteins 3–4A, 5A, and 5B.
Subsequently, cells were processed for double-label im-
munofluorescence with a polyclonal rabbit antiserum
against NS4B and murine mAbs against NS3, NS4A,
NS5A, or NS5B. In a second set of experiments (Fig. 3,
right panels), double-immunolabeling was performed in
UHCVcon-57 cells, which inducibly express the entire
24 h in the absence of tetracycline and subsequently processed for
roteins and mAb 4b-52 or, in the case of double-labeling with the mAb
ound primary antibodies were revealed with FITC- and TXR-conjugated
scopy as described under Materials and Methods. Horizontal sections
R) and green (FITC) channels are presented separately on the left anded for
arker p
S4B. B
microopen reading frame derived from a functional HCV con-
sensus cDNA. As shown in Fig. 3, NS4B colocalized with
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conditions. These observations do not necessarily imply,
but raise the possibility, that NS4B is a component of the
HCV replication complex. Furthermore, these experi-
ments demonstrate that the subcellular localization of
NS4B is not influenced by the coexpression of other HCV
proteins. NS4B per se, therefore, contains the signals
necessary for ER targeting.
We have previously shown that NS3 expressed alone
was diffusely distributed in the cytoplasm and nucleus
while coexpression of NS4A in cis or in trans directed
S3 to the ER membrane (Wo¨lk et al., 2000). Moreover, a
carboxy-terminal truncated NS5B protein was recently
found to be redistributed from the ER to the nucleus,
where it accumulated in nucleoli (Moradpour et al., un-
published data). Based on these observations, we per-
formed cotransfection experiments of NS4B with NS3 or
carboxy-terminal truncated NS5B constructs, to examine
FIG. 3. NS4B colocalizes with the other HCV nonstructural proteins.
ere transiently transfected with the CMV promotor-driven expre
CMVNS5Bcon (NS5B). Twenty-four hours later cells were processed f
ight panels, UHCVcon-57 cells were cultured for 24 h in the absenc
ntiserum WU151 against NS4B and murine mAbs 1B6, 8N, 11H, and 5
anels. Bound primary antibodies were revealed with FITC- and TXR-c
nd FITC.if interactions of NS4B with these nonstructural proteins
may direct them to the ER. However, the subcellulardistribution of these proteins was not influenced by the
coexpression of NS4B (data not shown). NS4B, therefore,
even if interacting in some way with NS3 and NS5B in the
context of a replication complex, was unable to direct
these proteins to the ER.
Association of NS4B with microsomal membranes in
vitro
In vitro transcription–translation and membrane sedi-
mentation analyses were performed to further character-
ize the membrane association of NS4B. To this end,
NS4B was translated in a coupled rabbit reticulocyte
lysate system in the presence or absence of microsomal
membranes. Subsequently, membrane-associated mate-
rial was separated by centrifugation and NS4B was
quantified in both fractions. As a control, MIA2, which
encodes the Gag, Gag-PR, and Gag-PR-Pol polyproteins
left panels, UNS4Bcon-4 cells cultured in the absence of tetracycline
construct pCMVNS3–4A (NS3, NS4A), pCMVNS5Acon (NS5A), or
le-immunolabeling as described under Materials and Methods. In the
tracycline, followed by double-immunolabeling. The polyclonal rabbit
against NS3, NS4A, NS5A, and NS5B, respectively, were used in both
ted secondary antibodies. Slides were viewed with filter sets for TXRIn the
ssion
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B-12B7of the murine intracisternal A-type particle (IAP) MIA14,
was used. The IAP Gag protein contains an amino-
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specifically to the ER membrane in transfected cells
(Welker et al., 1997) and in vitro (Fehrmann et al., manu-
script in preparation). The results of a typical experiment
are shown in Fig. 4. When NS4B was translated in the
absence of microsomal membranes only 26% was sub-
sequently found in the pellet. By contrast, 68% of the
NS4B protein sedimented when translation was per-
formed in the presence of microsomal membranes.
These results demonstrate that membrane association
of NS4B occurs also in vitro. Similarly, MIA2 associated
efficiently with microsomal membranes (8 vs 79% pel-
leted in reactions performed in the absence or presence
of microsomal membranes, respectively). Relatively more
NS4B compared to MIA2 was found in the pellet fraction
of in vitro transcription–translation reactions performed
n the absence of microsomal membranes. This is likely
consequence of some aggregation due to nonspecific
ydrophobic interactions. This tendency of NS4B could
e reduced by the addition of 0.01% digitonin to the
ranslation reactions (Fig. 5 and data not shown). A
inor, slightly faster migrating band was observed in the
S4B translations irrespective of the presence or ab-
ence of microsomal membranes (Fig. 4). This smaller
roduct, therefore, is likely a consequence of leaky scan-
ing and internal translation initiation at two ATGs lo-
ated 10 and 11 codons downstream from the engi-
eered translation initiation codon.
embrane association of NS4B occurs
otranslationally
To gain insight into the mechanism of membrane as-
FIG. 4. Association of NS4B with microsomal membranes in vitro. In
vitro transcription–translation reactions of pCMVNS4Bcon (left panel)
nd pTM1-MIA2 (right panel) were performed in the presence or ab-
ence of microsomal membranes as indicated. Subsequently, mem-
rane sedimentation analyses were performed as described under
aterials and Methods. Supernatant (S) and pellet fractions (P) were
pplied in equivalent amounts and separated by 12% SDS–PAGE.
35S]Methionine-labeled translation products were detected by autora-
iography. Quantitation was performed as described under Materials
nd Methods and values expressed in % are given at the top. Molecular
eight standards in kDa are indicated at left.ociation of NS4B we examined whether membrane tar-
eting of NS4B occurred co- or posttranslationally. In
w
eeukaryotic cells, ER transport of secreted and integral
membrane proteins is generally mediated by a signal
sequence that is recognized by the signal recognition
particle (SRP). The SRP interacts with the signal se-
quence of nascent polypeptide chains during translation
and directs the translation complex to the ER membrane.
By consequence, SRP-mediated ER transport occurs only
cotranslationally, while SRP-independent transport and
binding of hydrophobic proteins should also occur post-
translationally. To distinguish between these two possi-
bilities, therefore, microsomal membranes were added
to the reaction either during or after completion of in vitro
transcription–translation. Puromycin was added to the
reaction mixture in the posttranslational setting to stop
translation and to ascertain that polypeptides were re-
leased from ribosomes. As shown in Fig. 5, 47% of NS4B
was found in the pellet fraction in the cotranslational
reaction. By contrast, only 9% was found in the pellet
when the membranes were added posttranslationally.
This observation was confirmed in three independent
experiments with mean values of 40% of the NS4B pro-
tein pelleted in the cotranslational and 8% in the post-
translational setting. MIA2 Gag polyproteins, which are
directed to the ER via the SRP (Fehrmann et al., manu-
script in preparation), served as a control for cotransla-
tional ER membrane targeting (Fig. 5, middle panel). The
MIA4 construct, in which the amino-terminal signal se-
FIG. 5. Association of NS4B with the ER membrane occurs cotrans-
lationally. In vitro transcription–translation reactions of pCMVNS4Bcon
(top panel), pTM1-MIA2 (middle panel), and pTM1-MIA4 (bottom panel)
were performed in the presence (co) or absence of microsomal mem-
branes (post and 2). Digitonin at a concentration of 0.01% was present
in all translation reactions to reduce nonspecific aggregation and
sedimentation of NS4B. After 1 h, translation was stopped by the
addition of puromycin to 1.25 mM and microsomal membranes were
added to a set of the reactions without membranes (post) and incu-
bated for one additional hour. Subsequently, membrane sedimentation
analyses were performed as described under Materials and Methods.
Supernatant (S) and pellet fractions (P) were applied in equivalent
amounts and separated by 12% SDS–PAGE. [35S]Methionine-labeled
ranslation products were detected by autoradiography. Quantitationas performed as described under Materials and Methods and values
xpressed in % are given at the bottom of each panel.
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76 HU¨GLE ET AL.quence has been replaced by the membrane targeting
signal of the Src protein, represented a control for post-
translational ER targeting (Fig. 5, bottom panel). Mem-
brane association of this construct is mediated by my-
ristoylation of the engineered Src protein domain. Taken
together, these results demonstrate that NS4B is co-
translationally targeted to the ER membrane.
NS4B is an integral membrane protein
Membrane extraction experiments were performed to
characterize the nature of the association of NS4B with
the ER membrane. To this end, NS4B was translated in
vitro in the presence of microsomal membranes and the
ellet fraction was subsequently subjected to differential
xtraction methods. High-salt extraction (1 M NaCl) is
xpected to shield charges and weaken ionic interac-
ions that bind peripheral proteins to membranes either
irectly or indirectly through other membrane proteins
Kretzschmar et al., 1996). Treatment with 100 mM so-
dium carbonate, pH 11.5, should release peripheral pro-
teins by transforming microsomes into membrane sheets
(Fujiki et al., 1982). However, as shown in Fig. 6, NS4B
remained associated with microsomal membranes un-
der both conditions. Sixty percent of the protein re-
mained membrane-associated even under strongly de-
naturing conditions, i.e., treatment with 4 M urea. NS4B,
FIG. 6. NS4B is an integral membrane protein. In vitro transcription–
translation reactions of pCMVNS4Bcon were performed in the pres-
ence of microsomal membranes. Subsequently, reaction mixtures were
centrifuged for 15 min at 12,000 g to sediment microsomal membranes
ontaining associated NS4B protein. The supernatants were removed
nd the pellets were resuspended in NTE buffer, 1 M NaCl, 100 mM
odium carbonate, pH 11.5, 4 M urea, or 0.5% Triton X-100 and incu-
ated for 20 min at 4°C. Subsequently, membrane sedimentation anal-
ses were performed as described under Materials and Methods.
upernatant (S) and pellet fractions (P) were applied in equivalent
mounts and separated by 12% SDS–PAGE. [35S]Methionine-labeled
ranslation products were detected by autoradiography. Quantitation
as performed as described under Materials and Methods and values
xpressed in % are given at the bottom and depicted as bars. White
ars represent supernatant, while dark gray bars represent pellet
ractions.therefore, is tightly associated with the ER membrane
and behaves as an integral membrane protein. As acontrol, membranes were disrupted with 0.5% Triton
X-100. Under these conditions, 78% of the protein could
be extracted into the supernatant fraction.
NS4B is cytoplasmically oriented in the ER membrane
Proteinase protection experiments were performed to
determine the orientation of NS4B in the ER membrane.
As shown in Fig. 7, treatment of in vitro transcription–
ranslation reactions performed in the presence of mi-
rosomal membranes with proteinase K resulted in the
omplete disappearance of the NS4B signal. Thus, the
rotease sensitivity of NS4B indicates that the majority of
he protein is localized on the cytoplasmic side of the ER
embrane. In these experiments, preprolactin (ppl) was
sed as a control for the integrity of microsomal mem-
ranes. Ppl is directed to the ER membrane by interac-
ion of its signal sequence with the SRP. Signal sequence
leavage is performed by the signal peptidase located at
he luminal side of the ER membrane, followed by re-
ease of prolactin (pl) into the ER lumen. As shown in Fig.
, pl was protected from proteinase K digestion in the
resence of microsomal membranes. It became acces-
ible to proteolysis only after disruption of the mem-
ranes by detergent treatment. Because potentially ex-
sting transmembrane or luminal fragments of NS4B may
e very small and may lack methionine residues, we
epeated these experiments using [14C]leucine instead of
35S]methionine (12.3% of NS4B aa are leucine vs 2.3%
hat are methionine) as a radioactive label, followed by
nalyses on high-resolution 10 to 16.5% tricine gels.
owever, even under these more sensitive experimental
onditions we observed no protected fragments (data
ot shown).
FIG. 7. NS4B is cytoplasmically oriented on the ER membrane. In
itro transcription–translation reactions of pCMVNS4Bcon and pTM1-
pl were performed in the presence of microsomal membranes, fol-
owed by digestion with 50 mg/ml proteinase K (PK) for 1 h at 0°C in the
absence or presence of 0.1% Triton X-100 as indicated at the top.
Aliquots of each reaction were analyzed by 12% SDS–PAGE and visu-
alized by autoradiography. Molecular weight standards in kDa are
indicated on the left. ppl, preprolactin; pl, prolactin.
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NS4B is the least understood of all HCV proteins. No
unction has yet been ascribed to this protein in any of
he related Flaviviridae family members. In the present
nitial characterization, therefore, we investigated the
ubcellular localization and examined the membrane
ssociation of HCV NS4B. A novel mAb, designated 4b-
2, and cell lines inducibly expressing NS4B were gen-
rated for this purpose. Investigation of the viral life cycle
as been limited by the lack of reproducible cell culture
ystems permissive for HCV infection and replication. In
his context, the tetracycline-regulated cell lines de-
cribed here represent a well-defined and highly repro-
ucible model system to study structural and functional
roperties of NS4B.
Interestingly, inducible expression of NS4B in tetracy-
line-regulated cell lines revealed a dose-dependent cy-
otoxic effect. This effect was seen only at high expres-
ion levels and under low density seeding conditions,
hen cells are particularly vulnerable. We previously
ade similar observations in U-2 OS-derived cell lines
nducibly expressing the entire HCV polyprotein (Morad-
our et al., 1998b) or the structural region (Moradpour et
l., 1998c). However, under the same experimental con-
itions no cytotoxicity was observed for the core protein
Moradpour et al., 1996) or the nonstructural proteins 4A,
A, and 5B (Moradpour et al., unpublished data). NS4B,
herefore, appears to be more toxic compared to the
ther nonstructural HCV proteins. Intriguingly, recent
ork has shown that mutations in NS4B can attenuate
estivirus cytopathogenicity (Qu and Rice, submitted for
ublication). Clearly, the relevance of these findings for
he viral life cycle and the pathogenesis of hepatitis C
eeds to be investigated further.
Immunofluorescence analyses using the mAb 4b-52
nd subcellular fractionation experiments suggested
hat NS4B is associated with the ER. This was confirmed
y double-label confocal laser scanning microscopy, in
hich NS4B was found to colocalize with the ER-resident
rotein PDI. Preliminary data on the subcellular localiza-
ion has thus far been reported only for a GFP–NS4B
usion protein (Kim et al., 1999) and for a FLAG-tagged
S4B protein (Park et al., 2000). In both reports, the
ngineered proteins were localized in the cytoplasm, but
he subcellular compartment targeted by these proteins
as not further explored. Interestingly, NS4B of the re-
ated flavivirus Kunjin has been reported to translocate to
he nucleus during viral replication (Westaway et al.,
997a). In our studies, however, we never observed a
uclear staining of HCV NS4B. Localization of NS4B in
he ER was independent of the coexpression of other
CV proteins, indicating the presence of endogenous
ignals for ER targeting and membrane anchorage. Sim-
larly, we recently found that NS4A, NS5A, and NS5B
ere targeted to the ER when these nonstructural pro-eins were expressed individually (Moradpour et al., un-
ublished data). This is in contrast to NS3, which is
irected to the ER via interaction with its cofactor
olypeptide NS4A (Wo¨lk et al., 2000).
In the ER, NS4B colocalized with the other HCV non-
tructural proteins. This observation suggests that NS4B
s a component of the HCV replication complex. This
otion is supported by recent data indicating that NS4B,
ogether with NS3 and NS4A, is implicated in the mod-
lation of NS5A hyperphosphorylation (Koch and Barten-
chlager, 1999; Neddermann et al., 1999) and by the
emonstration of a physical interaction between NS4A
nd a NS4B–5A cleavage substrate (Lin et al., 1997).
ormation of a membrane-associated replication com-
lex is a characteristic feature of positive-strand RNA
iruses and has been characterized in some detail, e.g.,
n the case of poliovirus (Bienz et al., 1992; Egger et al.,
996, 2000; Suhy et al., 2000) and the flavivirus Kunjin
Westaway et al., 1997b; Mackenzie et al., 1999; Khro-
mykh et al., 2000). The mechanisms of membrane asso-
ciation and the protein–protein interactions involved in
the formation of the HCV replication complex, however,
are poorly understood. A subtly regulated and highly
complex scenario is likely, not the least in view of recent
data on membrane targeting of the HCV NS3–4A com-
plex by the NS4A polypeptide (Wo¨lk et al., 2000) and the
conformational changes of this complex predicted for
cis- and trans-processing events (Yao et al., 1999).
The membrane association of NS4B was further ex-
plored by in vitro transcription–translation experiments
performed in the presence or absence of microsomal
membranes isolated from canine pancreas. An earlier
study suggested that most HCV nonstructural proteins
are more or less membrane-associated (Hijikata et al.,
1993). NS4B, however, was not specifically addressed in
that study. Our results demonstrate a clear membrane
association also in vitro. About 40–70% of NS4B protein
sedimented after in vitro transcription–translation in the
presence of microsomal membranes, while only 5–30%
was pelleted, presumably as a result of nonspecific hy-
drophobic interactions, when microsomal membranes
were omitted from the reaction.
In mammalian cells, membrane and secreted proteins
are directed first to the ER membrane. Protein transport
to the ER is most commonly mediated by signal se-
quences that are cotranslationally bound by the SRP and
targeted to the docking protein and the Sec61p complex
on the ER membrane (Walter and Johnson, 1994; Matlack
et al., 1998). This complex forms a channel through which
polypeptides are translocated and released into the ER
lumen as soluble proteins or inserted into the membrane
as transmembrane proteins (Schatz and Dobberstein,
1996; Matlack et al., 1998). Posttranslational membrane
targeting is common in yeast (Deshaies et al., 1991;
Panzner et al., 1995) and bacteria (Schatz and Beckwith,
1990; Wickner and Leonard, 1996), but few examples
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78 HU¨GLE ET AL.have been described for mammalian cells (Anderson et
al., 1983; Mu¨ller and Zimmermann, 1987; Kutay et al.,
995). Posttranslational membrane targeting does not
nvolve the SRP. The cotranslational membrane associ-
tion of NS4B, therefore, suggests an SRP-dependent
echanism of membrane targeting. Since NS4B does
ot possess a classical amino-terminal signal sequence,
e propose that one or more of the internal hydrophobic
equences function as signal anchor sequences. The
ydrophobicity profiles of NS4B are similar among flavi-
iruses, with a conserved hydrophobic plateau in the
enter and two short hydrophobic domains at the car-
oxy terminus. In this context, we found that deletion of
he carboxy-terminal 96 aa, including two relatively con-
erved highly hydrophobic domains, did not alter the
ubcellular distribution of NS4B (data not illustrated). It is
ossible, therefore, that one or multiple determinants
ithin the long hydrophobic domain in the center of
S4B promote membrane association.
In membrane extraction and proteinase protection as-
ays NS4B behaved as a cytoplasmically oriented inte-
ral membrane protein. However, no protected trans-
embrane or luminal fragments were detected after ra-
ioactive labeling with [35S]methionine or [14C]leucine.
This was somewhat unexpected since in the case of the
related yellow fever virus NS4B has been shown to span
the ER membrane at least once with multiple membrane-
associated hydrophobic segments and cytoplasmic
loops (Lin et al., 1993). Furthermore, membrane topology
models predicted by PredictProtein (on the World Wide
Web at URL www.embl-heidelberg.de) or TMHMM (URL:
www.cbs.dtu.dk) and TopPred2 (URL: www.biokemi.
su.se) featured six or four internal transmembrane do-
mains, respectively. On the other hand, observations
similar to ours, with a complete sensitivity to proteinase
digestion, have been reported for NS4B of the related
West Nile, Kunjin, and Dengue viruses (Wengler et al.,
1990; Cauchi et al., 1991; Westaway et al., 1997a). A
refined membrane topology model of HCV NS4B will be
the subject of further experimentation.
In summary, we have shown that the HCV NS4B pro-
tein is tightly associated with the ER membrane, where it
behaved as a cytoplasmically oriented integral mem-
brane protein and colocalized with the other nonstruc-
tural proteins. The data suggest that NS4B is a compo-
nent of a membrane-associated cytoplasmic HCV repli-
cation complex. An efficient replication system will be
essential to further define the role of NS4B in the viral life
cycle.
MATERIALS AND METHODS
Expression constructs
A fragment comprising nt 5475 to 6258 (aa 1712 to
1972) of a functional HCV H strain consensus cDNA
(genotype 1a) was amplified by PCR from pBRTM/HCV1-3011con (Kolykhalov et al., 1997) using sense primer
59-GAGAATTCACCATGTCTCAGCACTTACCGTACATCGA-
GCAAGGG-39 (EcoRI site underlined, engineered trans-
lation initiation codon in boldface) and reverse primer
59-GCTGTCTAGATTAGCATGGAGTGGTACACTCCGAGC-
TTATCC-39 (XbaI site underlined, engineered ochre stop
codon in boldface). The amplification product was
cloned into the EcoRI-XbaI sites of pUHD10-3 (Gossen
and Bujard, 1992) and pcDNA3.1 (Invitrogen, San Diego,
CA) to yield the expression constructs pUHDNS4Bcon
and pCMVNS4Bcon, respectively. pUHDNS4Bcon allows
expression of NS4B under the transcriptional control of a
tTA-dependent promoter (Fig. 1A). pCMVNS4Bcon allows
both eukaryotic expression from a CMV promoter and in
vitro transcription from a T7 RNA polymerase promotor.
pCMVNS3–4A (Wo¨lk et al., 2000), pCMVNS5Acon, and
CMVNS5Bcon (Moradpour et al., unpublished data) al-
ow the CMV promotor-driven expression of the HCV
S3–4A complex, NS5A, or NS5B, respectively.
pTM1 (Moss et al., 1990) allows high-level in vitro
xpression from a T7 RNA polymerase promotor fol-
owed by the encephalomyocarditis virus internal ribo-
ome entry site. pTM1-MIA2 contains almost the entire
ag-pro-pol region (nt 594 to 4102) of the murine IAP
IA14 (Fehrmann et al., 1997; Mietz et al., 1987). Plas-
ids pTM1-MIA4 and pTM1-ppl will be described in
etail elsewhere (Fehrmann et al., manuscript in prepa-
ation). Briefly, pTM1-MIA4 was derived from pL-MIA4
Welker et al., 1997) and allows expression of a MIA14
ag gene of which the first 28 codons have been re-
laced by the membrane-targeting signal of the Src pro-
ein. pTM1-ppl contains the entire coding region of bo-
ine ppl derived from pSPB4 (Schlenstedt et al., 1992).
etracycline-regulated cell lines
Tetracycline-regulated cell lines were generated as
reviously described (Moradpour et al., 1996, 1998b,c;
Wo¨lk et al., 2000). In brief, the constitutively tTA-express-
ing, U-2 OS human osteosarcoma-derived founder cell
line UTA-6 (Englert et al., 1995) was cotransfected with
pUHDNS4Bcon and pBabepuro (Morgenstern and Land,
1990). G418 and puromycin double-resistant clones were
isolated and screened for tightly regulated NS4B expres-
sion by indirect immunofluorescence microscopy and
immunoblot. UHCVcon-57 cells, which inducibly express
the entire open reading frame derived from a functional
HCV H strain consensus cDNA (Kolykhalov et al., 1997),
and UGFP-9.22 cells, which inducibly express an en-
hanced GFP derived from pEGFP-N1 (Clontech, Palo
Alto, CA), will be described in detail elsewhere (Morad-
pour et al., manuscript in preparation).
AntibodiesNS4B derived from a genotype 1b HCV cDNA was
expressed in E. coli and used as an antigen for the
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79HCV NS4B PROTEINproduction of mAbs. Spleen cells from female BALB/c
mice immunized with this recombinant protein were
fused with the X63-Ag8.653 myeloma cell line (American
Type Culture Collection, Rockville, MD). Hybridomas
were selected and supernatants were screened by
ELISA essentially as described (Harlow and Lane, 1988).
Hybridomas immunoreactive with recombinant NS4B
protein were cloned at least twice by limiting dilution.
The polyclonal rabbit antiserum WU151 against NS4B
was produced by immunization of rabbits with a syn-
thetic peptide corresponding to the first 18 aa of geno-
type 1a NS4B (SQHLPYIEQGMMLAEQFK; Lin et al., un-
published data). A pool of high-titer anti-HCV-positive
sera from 10 patients with chronic hepatitis C was used
as a source of primary antibodies in some immunoblot
analyses. The NS3-specific mAb 1B6 was described pre-
viously (Wo¨lk et al., 2000). mAbs 8N against NS4A and
11H against NS5A were kindly provided by Jan Albert
Hellings and Winand Habets (Organon Teknika B.V., Box-
tel, The Netherlands). mAb 5B-12B7 against NS5B will be
described elsewhere (Moradpour et al., manuscript in
preparation). A polyclonal rabbit antiserum against PDI
was obtained from StressGen (Victoria, BC, Canada). The
mAb G1/93 against human ERGIC-53 (Schweizer et al.,
1988) was kindly provided by Hans-Peter Hauri (Univer-
sity of Basel, Switzerland). A polyclonal rabbit antiserum
to Man II (Moremen, 1991) was kindly provided by Kelley
Moremen (University of Georgia, Athens, GA). The mAb
JL-8 against GFP was purchased from Clontech.
Indirect immunofluorescence and confocal laser
scanning microscopy
Indirect immunofluorescence microscopy was per-
formed as described previously (Moradpour et al., 1996,
1998b). In brief, cells grown as monolayers on glass
coverslips were fixed with 2% paraformaldehyde, perme-
abilized with 0.05% saponin, and incubated with primary
antibodies in phosphate-buffered saline containing 3%
bovine serum albumin and 0.05% saponin. Bound pri-
mary antibody was revealed with fluorescein isothiocya-
nate (FITC)-conjugated goat F(ab9)2 fragment to mouse
gG F(ab9)2 (Cappel, Durham, NC) or sheep F(ab9)2 frag-
ent to rabbit IgG (Boehringer Mannheim, Germany). For
olocalization experiments, a Texas Red (TXR)-conju-
ated sheep F(ab9)2 to mouse IgG (ICN/Cappel, Aurora,
H) was used as a secondary antibody to reveal bound
urine mAbs. Coverslips were mounted in SlowFade
Molecular Probes, Eugene, OR) and examined with a
eiss Axiovert photomicroscope equipped with an epi-
luorescence attachment. Confocal laser scanning mi-
roscopy was performed using a Zeiss LSM 410 micro-
cope and images were processed with the Adobe Pho-
oshop program, version 3.0.5.
p
western blot analysis
Western blot analysis was performed as described
reviously (Moradpour et al., 1996, 1998b).
ubcellular fractionation
Subcellular fractionation was performed essentially as
escribed previously (Moradpour et al., 1996). In brief,
3 107 UNS4Bcon-4 or UGFP-9.22 cells cultured for 48 h
in the absence of tetracycline were dounce-homoge-
nized in a hypotonic buffer containing 10 mM Tris–HCl,
pH 7.5, and 2 mM MgCl2, followed by centrifugation at
000 g for 5 min to yield a nuclear pellet. The supernatant
raction was adjusted to 0.25 M sucrose and a mitochon-
rial pellet was obtained by centrifugation at 9000 g for
0 min. Finally, a microsomal pellet was separated from
he cytosolic supernatant by centrifugation at 105,000 g
or 40 min.
n vitro transcription–translation
In vitro transcription–translation was performed using
he TNT T7 coupled rabbit reticulocyte lysate system
Promega, Madison, WI) essentially following the manu-
acturer’s recommendations. Reactions were incubated
or 90 min at 30°C in the presence of 0.75 mCi/ml
35S]methionine (Amersham, UK) in a volume of 25 ml.
Where indicated, 1.5 ml canine pancreatic microsomes (a
ift from Richard Zimmermann, Medizinische Biochemie
nd Molekularbiologie, Universita¨t des Saarlandes,
omburg, Germany) and digitonin at a final concentra-
ion of 0.01% were added. Initial titration experiments
ndicated that 1.5 ml microsomal membranes per 25 ml
coupled in vitro transcription–translation reaction was
optimal since larger quantities led to a strong reduction
of translation efficiency.
For membrane sedimentation analyses, 15 ml NTE
buffer (100 mM NaCl, 10 mM Tris–HCl, pH 8.0, 1 mM
EDTA) was added after completion of the in vitro tran-
scription–translation reaction, followed by centrifugation
at 12,000 g for 15 min. Supernatants were collected and
pellets were resuspended in 40 ml NTE buffer. Subse-
quently, pellet and supernatant fractions were separated
by SDS–PAGE and analyzed by autoradiography. Gels
were scanned on a Fuji BAS1000 phosphoimager and
analyzed using the Fuji MacBAS V2.4 software.
For analyses of co- and posttranslational membrane
association, microsomal membranes were added to the
reactions either during or for 1 h at 30°C after completion
of in vitro transcription–translation. In the latter setting,
translation was stopped by 1.25 mM puromycin prior to
the addition of microsomal membranes.
For membrane extraction experiments, the pellets
from 15 ml in vitro transcription–translation reactionserformed in the presence of microsomal membranes
ere resuspended in 40 ml NTE buffer, 1 M NaCl, 100
s80 HU¨GLE ET AL.mM sodium carbonate, pH 11.5, 4 M urea, or 0.5% Triton
X-100 and incubated for 20 min at 4°C. Subsequently,
membrane sedimentation analyses were performed as
described above.
For proteinase protection assays, 1 ml proteinase K
tock solution (500 mg/ml 3 final concentration of 50
mg/ml) was added to a 10-ml in vitro transcription–trans-
lation reaction containing microsomal membranes. After
30 min incubation at 4°C, proteolysis was terminated by
the addition of 2 ml 12.5 mM phenylmethylsulfonyl fluo-
ride, followed by SDS–PAGE of the samples.
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